Skip to content
5th mRNA-Based Therapeutics Summit logo No strap WO

Ran July 21-23, 2025 | Boston, MA

  • About
    • About Event
    • World RNA Series
    • Hanson Wade
  • What’s On?
    • 2025 Event Guide
    • 2025 Speaker Faculty
  • Partner
    • Why Partner?
    • Partners
  • Take Part
    • Register Interest
    • Contact Us
Event Guide
Register Interest
5th mRNA-Based Therapeutics Summit logo No strap WO
  • About
    • About Event
    • World RNA Series
    • Hanson Wade
  • What’s On?
    • 2025 Event Guide
    • 2025 Speaker Faculty
  • Partner
    • Why Partner?
    • Partners
  • Take Part
    • Register Interest
    • Contact Us

Ran July 21-23, 2025 | Boston, MA

Event Guide
Register Interest

Biopharma Business Development & Investors Panel: Secure the Financial Future of mRNA Technology Through Trusting Investor Partnerships

Biopharma Business Development & Investors Panel: Secure the Financial Future of mRNA Technology Through Trusting Investor Partnerships

By | 24 February 2025

Download the Full Event Guide to see session details.

Recent Posts

    Recent Comments

    No comments to show.
    Contact

    Phone
    UK: +44 (0)20 3141 8700
    US: +1 617 455 4188

    Email
    info@hansonwade.com

    Join Our Team

    We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

    Click here to learn about careers.

    About Us

    Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

    Explore Our Products
    Conferences Beacon
    Intelligence
    Stay Connected
    Search
    Organized By

    Terms & Conditions
    Privacy Policy

    A Hanson Wade Group Company

    hw-grou-logo
    Scroll To Top
    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.